Characteristics of Patients with Diabetes Initiating Sodium Glucose Co-transporter-2 Inhibitors (SGLT2i): Real-World Results from Three Administrative Databases in Japan.

Diabetes Ther · 2019 · PMC6437244 · PMID 30730037

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Over the study period, there was a decreasing trend in SGLT2i prescriptions initiated from the clinics (ESM Fig. 1).

also in 47,180 other papers

an increasing trendno p-value reported

Over the study period, there was an increasing trend in mean age at index among SGLT2i users (Fig. 3 ), with an increase in the proportion of patients aged ≥ 65 years in all datasets (ESM Fig. 3).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.